Share：
Share this content in WeChat
X
[Chinese][PDF]75171
• Clinical Article •
The value of magnetic resonance imaging in the diagnosis of clear cell hepatocellular carcinoma
LIU Bin  YANG Xue  CHEN Feng  SUN Jun  LI Hongjun 

Cite this article as: Liu B, Yang X, Chen F, et al. The value of magnetic resonance imaging in the diagnosis of clear cell hepatocellular carcinoma[J]. Chin J Magn Reson Imaging, 2021, 12(5): 21-24. DOI:10.12015/issn.1674-8034.2021.05.005.


[Abstract] Objective The purpose of this study is to improve the accuracy of preoperative diagnosis by compare and analyze the clinical and magnetic resonance imaging features of clear cell hepatocellular carcinoma and common hepatocellular carcinoma. Materials andMethods We analyzed clinical and magnetic resonance imaging features of 33 cases of clear cell hepatocellular carcinoma and 87 cases of common hepatocellular carcinoma confirmed by pathological results from August 2014 to May 2020. All patients underwent MR plain scan and multi-phase enhanced scan before operation. We obtained MR imaging features, age, gender, hepatitis type and AFP result of all patients from picture archiving and communication systems, and used SPSS 21.0 to perform statistical analysis on the results.Results The infection rate of hepatitis C in clear cell hepatocellular carcinoma was 24.2% (8/33), and the infection rate of hepatitis C in common hepatocellular carcinoma was 4.6% (4/87). The incidence of intratumoral fat signal in clear cell hepatocellular carcinoma was 21.2% (7/33), and the incidence of intratumoral fat signal in common hepatocellular carcinoma was 2.3% (2/87). The incidence of intratumoral artery sign in clear cell hepatocellular carcinoma was 27.3% (9/33), and the incidence of intratumoral artery sign in common hepatocellular carcinoma was 49.4% (43/87).Conclusions Compared with common hepatocellular carcinoma, clear cell hepatocellular carcinoma present higher infection rate of hepatitis C, higher incidence of intratumoral fatty signal and lower incidence of intratumoral artery sign. It could provide certain guiding value for the accurate diagnosis of clear cell hepatocellular carcinoma before surgery.
[Keywords] magnetic resonance imaging；clear cell hepatocellular carcinoma；common hepatocellular carcinoma；intratumoral fat signal；intratumoral artery sign

LIU Bin   YANG Xue   CHEN Feng   SUN Jun   LI Hongjun*  

Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China

Li HJ, E-mail: lihongjun00113@ccmu.edu.cn

Conflicts of interest   None.

ACKNOWLEDGMENTS This work was part of National Natural Science Foundation of China (No. 61936013).
Received  2021-01-23
Accepted  2021-03-25
DOI: 10.12015/issn.1674-8034.2021.05.005
Cite this article as: Liu B, Yang X, Chen F, et al. The value of magnetic resonance imaging in the diagnosis of clear cell hepatocellular carcinoma[J]. Chin J Magn Reson Imaging, 2021, 12(5): 21-24. DOI:10.12015/issn.1674-8034.2021.05.005.

1
Kiruthiga C, Devi KP, Nabavi SM, et al. Autophagy: a potential therapeutic target of polyphenols in hepatocellular carcinoma[J]. Hepatology, 2020, 12(3): 562. DOI: 10.3390/cancers12030562.
2
Dauki AM, Blachly JS, Kautto EA, et al. Transcriptionally active androgen receptor splice variants promote hepatocellular carcinoma progression[J]. Cancer Res, 2020, 80(3): 561-575. DOI: 10.1158/0008-5472.CAN-19-1117.
3
Bi JG, Zheng JF, Li Q, et al. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma[J]. Int J Biochem Cell Biol, 2019, 106(1): 107-116. DOI: 10.1016/j.biocel.2018.11.011.
4
Department of Medical Administration, National Health and Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. Chin J Hepatol, 2020, 28(2): 112-128. DOI: 10.3760/cma.j.issn.1007-3418.2020.02.004.
5
Xu W, Ge PL, Liao WJ, et al. Edmondson grade predicts survival of patients with primary clear cell carcinoma of liver after curative resection: a retrospective study with long-term follow-up[J]. Asia Pac J Clin Oncol, 2017, 13(5): e312-e320. DOI: 10.1111/ajco.12494.
6
Chen ZS, Zhu SL, Qi LN, et al. Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy[J]. Onco Targets Ther, 2016, 6(9): 4129-4135. DOI: 10.2147/OTT.S104827.
7
Shang YK. The mutational characteristics of clear cell hepatocellular carcinoma[D]. Beijing: Beijing Jiaotong University, 2018.
8
Zhang ZY, Xie H, Chen P, et al. Development and identification of a nomogram prognostic model for patients with primary clear cell carcinoma of the liver[J]. Med Sci Monit, 2020, 23(26): e919789. DOI: 10.12659/MSM.919789.
9
Sakhuja P, Mishra PK, Rajesh R, et al. Clear cell hepatocellular carcinoma: back to the basics for diagnosis[J]. Case Reports, 2015, 11(3): 656. DOI: 10.4103/0973-1482.136041.
10
Li T, Fan J, Qin LX, et al. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver[J]. Ann Surg Oncol, 2011, 18(7): 1955-1963. DOI: 10.1245/s10434-010-1540-z.
11
Zhang N, Xu WB. Imaging features of primary clear cell carcinoma liver[J]. J Pract Radiol, 2019, 35(2): 321-323.
12
Emile JF, Lemoine A, Azoulay D, et al. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma[J]. Histopathology, 2001, 38(3): 225-231. DOI: 10.1046/j.1365-2559.2001.01096.x.
13
Liu ZS, Ma WD, Li HK, et al. Clinicopathological and prognostic features of primary clear cell carcinoma of the liver. Hepatol Res, 2008, 38(3): 291-99. DOI: 10.1111/j.1872-034X.2007.00264.x.
14
Liu QY, Li HG, Gao M, et al. Primary clear cell carcinoma in the liver: CT and MRI findings. World J Gastroenterol, 2011, 17(7): 946-952. DOI: 10.3748/wjg.v17.i7.946.
15
Chen F, Zhao J, Li HJ, et al. Imaging features of primary clear carcinoma of liver and comparative analysis study[J]. J Clin Radiol, 2019, 38(8): 1418-1423. DOI: 10.13437/j.cnki.jcr.20190828.024.
16
Yao P, Li XB, Li XJ. Diagnostic value of CT and MRI imaging in microvascular infiltration in patients with primary liver cancer[J]. Chin J CT MRI, 2021, 19(1): 117-119.
17
Peng J, Zhang J, Zhang QF, et al. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma[J]. Diagn Interv Radiol, 2018, 24(3): 121-127. DOI: 10.5152/dir.2018.17467.
18
Jabbour TE, Lagana SM, Lee H. Update on hepatocellular carcinoma: pathologists' review[J]. World J Gastroenterol, 2019, 25(14): 1653-1665. DOI: 10.3748/wjg.v25.i14.1653.
19
Bannasch P, Ribback S, Su Q, et al. Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(6): 570-594. DOI: 10.1016/S1499-3872(17)60071-7.
20
Yang SH, Watanabe J, Nakashima O, et al. Clinicopathologic study on clear cell hepatocellular carcinoma[J]. Pathol Int, 1996, 46(7): 503-509. DOI: 10.1111/j.1440-1827.1996.tb03645.x.
21
Lai CL, Wu PC, Lam KC et al. Histologic prognostic indicators in hepatocellular carcinoma[J]. Cancer, 1979, 44(5): 1677-1683. DOI: 10.1002/1097-0142(197911)44:5<1677::aid-cncr2820440522>3.0.co;2-d.
22
Fan M, Liu Y, Xia FD, et al. Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma[J]. Tumori, 2013, 99(6): 689-696. DOI: 10.1700/1390.15457.

PREV The value of minimum apparent diffusion coefficient in evaluating the invasiveness of hepatocellular carcinoma
NEXT Evaluation of computer tomography and magnetic resonance imaging in the classification and viability of hepatic cystic echinococcosis
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn